Predictive and prognostic factors in metastatic renal carcinoma

04/2020

MUDr. Jindřich Kopecký, Ph.D.

Klinika onkologie a radioterapie LF UK a FN, Hradec Králové

SUMMARY

Current treatment algorithms for metastatic renal cell carcinoma are based on the sequential use of drugs. It is therefore advisable to have prognostic and predictive markers available before starting treatment so that the right drug can be chosen for a particular patient with a particular type of kidney tumor. The following article discusses potential biomarkers.

Key words

kidney cancer, tyrosine kinase inhibitors, immunotherapy, prognostic and predictive markers